The Joint BOPA and PASG Position Statement on Safer Handling of Hazardous SACT Drugs outlines a shared commitment to ensuring safe and effective practices in the preparation, handling, administration, and disposal of Systemic Anti-Cancer Therapy (SACT) and cytotoxic medicines. Read more

We are very pleased to share that the SHBN and RCN’s recent Parliamentary Reception marked a historic milestone, the first time the issue of occupational exposure to hazardous medicinal products (HMPs) has been formally raised in Parliament. Read more

New polling from the Royal College of General Practitioners warns that excessive GP workloads are putting patient safety at risk, underscoring the urgent need for investment and safe staffing across primary care. Read more